Genetic modifiers of multiple sclerosis progression, severity and onset.

[1]  A. Traboulsee,et al.  Analysis of CH25H in multiple sclerosis and neuromyelitis optica , 2016, Journal of Neuroimmunology.

[2]  I. Wilhelm,et al.  Regulation of NOD‐like receptors and inflammasome activation in cerebral endothelial cells , 2015, Journal of neurochemistry.

[3]  C. Bladen,et al.  The Deubiquitinating Enzyme USP5 Modulates Neuropathic and Inflammatory Pain by Enhancing Cav3.2 Channel Activity , 2014, Neuron.

[4]  Yinshan Zhao,et al.  Progressive multiple sclerosis does not associate with rs996343 and rs2046748 , 2014, Multiple sclerosis.

[5]  A. Traboulsee,et al.  Genetic variants in IL2RA and IL7R affect multiple sclerosis disease risk and progression , 2014, neurogenetics.

[6]  A. Ciechanover,et al.  Multiple Sclerosis Autoantigen Myelin Basic Protein Escapes Control by Ubiquitination during Proteasomal Degradation* , 2014, The Journal of Biological Chemistry.

[7]  V. Jevtovic-Todorovic,et al.  Targeting of CaV3.2 T-type calcium channels in peripheral sensory neurons for the treatment of painful diabetic neuropathy , 2014, Pflügers Archiv - European Journal of Physiology.

[8]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[9]  D. Görlich,et al.  Myelin Membrane Assembly Is Driven by a Phase Transition of Myelin Basic Proteins Into a Cohesive Protein Meshwork , 2013, PLoS biology.

[10]  Xihong Lin,et al.  Optimal tests for rare variant effects in sequencing association studies. , 2012, Biostatistics.

[11]  Xihong Lin,et al.  Rare-variant association testing for sequencing data with the sequence kernel association test. , 2011, American journal of human genetics.

[12]  V. Jevtovic-Todorovic,et al.  In vivo silencing of the CaV3.2 T-type calcium channels in sensory neurons alleviates hyperalgesia in rats with streptozocin-induced diabetic neuropathy , 2009, PAIN®.

[13]  R. Gold,et al.  Variation in the IL7RA and IL2RA genes in German multiple sclerosis patients. , 2009, Journal of autoimmunity.

[14]  R. Dohmen,et al.  PACemakers of proteasome core particle assembly. , 2008, Structure.

[15]  A. Sadovnick,et al.  Analysis of 45 candidate genes for disease modifying activity in multiple sclerosis , 2008, Journal of Neurology.

[16]  V. Jevtovic-Todorovic,et al.  Upregulation of the T-type calcium current in small rat sensory neurons after chronic constrictive injury of the sciatic nerve. , 2008, Journal of neurophysiology.

[17]  Manuel A. R. Ferreira,et al.  PLINK: a tool set for whole-genome association and population-based linkage analyses. , 2007, American journal of human genetics.

[18]  J. Gustafsson,et al.  Anti-inflammatory nuclear receptor superfamily in multiple sclerosis patients from Sardinia and Sweden , 2005, Neurobiology of Disease.

[19]  A. Compston,et al.  Recommended diagnostic criteria for multiple sclerosis: Guidelines from the international panel on the diagnosis of multiple sclerosis , 2001, Annals of neurology.

[20]  J. Noseworthy.  Progress in determining the causes and treatment of multiple sclerosis , 1999, Nature.

[21]  Edmund M. Talley,et al.  Differential Distribution of Three Members of a Gene Family Encoding Low Voltage-Activated (T-Type) Calcium Channels , 1999, The Journal of Neuroscience.

[22]  N. Risch,et al.  Canadian Collaborative Project on Genetic Susceptibility to MS, Phase 2: Rationale and Method , 1998, Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.

[23]  B Bass,et al.  The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability. , 1989, Brain : a journal of neurology.

[24]  J. Kurtzke.  Rating neurologic impairment in multiple sclerosis , 1983, Neurology.

[25]  D. Silberberg,et al.  New diagnostic criteria for multiple sclerosis: Guidelines for research protocols , 1983, Annals of neurology.

[26]  G. Stewart,et al.  A genome-wide association study in progressive multiple sclerosis , 2012, Multiple sclerosis.

[27]  Keiko Tanaka,et al.  Environmental Factors and Multiple Sclerosis: A Systematic Review , 2010 .

[28]  G. Salemi,et al.  Multiple Sclerosis Severity Score: Using disability and disease duration to rate disease severity , 2005, Neurology.